Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v23-FR Version v14-EN
Language French English
Date Updated 2021-12-13 2021-10-18
Drug Identification Number 00755834 00755834
Brand name APO-TIMOP APO-TIMOP
Common or Proper name TIMOLOL OPTHALMIC TIMOLOL OPTHALMIC
Company Name APOTEX INC APOTEX INC
Ingredients TIMOLOL TIMOLOL
Strength(s) 0.5% 0.5%
Dosage form(s) SOLUTION SOLUTION
Route of administration OPHTHALMIC OPHTHALMIC OPHTHALMIC OPHTHALMIC
Packaging size 10 ML 10 ML
ATC code S01ED S01ED
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2021-11-15 2021-11-15
Actual start date 2021-10-27
Estimated end date 2021-12-10 2021-12-15
Actual end date 2021-12-10
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments